Diagen Biotechnology Systems Inc. was founded in 1998 and established its R&D department in 2008. With support from the TUBITAK TEYDEB Industry-University Collaboration, it began developing diagnostic products in the fields of Molecular Genetics and Cytogenetics (Real-time PCR kits, FISH probes), Molecular (Real-time PCR) Microbiology, and Serological (ELISA) Microbiology.

​

Diagen closely follows academic research and developing technology in our country and globally, and with a dynamic and constantly evolving structure, it continues to develop diagnostic products in the fields of Medicine, Veterinary, and Food Health.

Today, Diagen Biotechnology Systems Inc. exports over 200 products to many countries worldwide, contributing to the national economy through import substitution thanks to the high-tech diagnostic products produced in collaboration with our nationally trained scientists.

​

Since the beginning of the COVID-19 pandemic, it has accelerated its product development efforts for disease diagnosis and has begun promoting and selling Real Time PCR kits to international markets by receiving approval from the Ministry of Health Public Health Institution at the end of May 2020.